Skip to main content
. 2019 Oct 17;9(26):7981–8000. doi: 10.7150/thno.37568

Figure 10.

Figure 10

Schematic illustration of the prodrug vesicles for improved cancer immunotherapy by combing ICD induction and CD47 blockade. (a) Schematic design of the dual-responsive, e.g., acidity and MMP-2 prodrug vesicles. (b) Simplified mechanism of NP-mediated chemo-immunotherapy and CD47 blockade, which inhibited tumor growth, distant metastasis, and relapse. Adapted with permission from 140, copyright 2019 John Wiley and Sons.